Abstract

Up-Front Use of Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: The Emperor Has No Clothes

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Adjuvant Endocrine Therapy for Breast Cancer: Don't Ditch the Switch!
N E Davidson ... S Puhalla
JNCI Journal of the National Cancer Institute | VOL. 103
N E Davidson, et. al.N E Davidson ... S Puhalla
22 Aug 2011
Optimal Use of Aromatase Inhibitors: To Lead or to Follow?
Eric P Winer ... Nancy U Lin
Journal of Clinical Oncology | VOL. 25
Eric P Winer, et. al.Eric P Winer ... Nancy U Lin
11 Jun 2007
Advances in Screening, Diagnosis, and Treatment of Breast Cancer
Betty A Mincey ... Edith A Perez
Mayo Clinic Proceedings | VOL. 79
Betty A Mincey, et. al.Betty A Mincey ... Edith A Perez
01 Jun 2004
Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
Alberto Ocaña ... Eitan Amir
JNCI: Journal of the National Cancer Institute | VOL. 103
Alberto Ocaña, et. al.Alberto Ocaña ... Eitan Amir
22 Aug 2011
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers